相关实验视频
Updated: Jun 19, 2025

03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
396
过度表达COL5A1与人类宫癌的预后不佳相关
Xiaoling Duan1, Danjuan Ye1, Jia Yuan2,3
1Department of Obstetrics and Gynaecology, Jinshan Hospital, Fudan University, Shanghai, China.
The International journal of biological markers
|July 23, 2024
概括
原体V型α1链 (COL5A1) 在宫癌组织中过度表达. 高COL5A1表达与较差的患者存活率有关,这表明其作为预后生物标志物的潜力.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 遗传学 是一个遗传学.
背景情况:
- 宫癌是全世界妇女死亡的主要原因之一.
- 了解分子标记对于改善患者的治疗结果至关重要.
- 原体V型α1链 (COL5A1) 在宫癌预后中的作用正在研究中.
研究的目的:
- 为了研究子宫癌中COL5A1的表达水平.
- 为了确定COL5A1表达在患者预后中的临床相关性.
- 在宫癌中探索COL5A1的潜在基因组改变.
主要方法:
- 免疫组织化学 (IHC) 用于评估瘤和相邻的正常组织中的COL5A1蛋白表达.
- 使用R软件和GEPIA进行了生存分析.
- 用cBioPortal数据库分析基因突变和改变数据.
主要成果:
- 与正常组织相比,在宫癌组织中显著过度表达了COL5A1蛋白 (P < 0.001).
- 高的COL5A1表达与较短的整体存活率 (P = 0.031) 和无病存活率 (P = 0.042) 相相关.
- 在4%的宫癌患者中,发现了COL5A1的基因组变化,其中氧化作为翻译后修改.
结论:
- COL5A1是一种潜在的组织生物标志物,可预测宫癌患者的不良预后.
- 升高的COL5A1表达与不良的生存结果有关.
- COL5A1可能是宫癌管理中的临床应用的新目标.
相关概念视频
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer-Critical Genes I: Proto-oncogenes
8.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K

